PointState Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-13,333
Closed -$5.57M 143
2015
Q1
$5.57M Buy
+13,333
New +$5.57M 0.08% 90